Back

Do substrate modification in catheter ablation of atrial fibrillation increase the incidence acute complications: analysis of 10,795 procedures

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Treatment of atrial fibrillation Rhythm Control, Catheter Ablation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Yuji Murakawa

Mizonokuchi Hospital- Teikyo University School of Medicine, Kawasaki (Japan)

9 More presentations in this session

Presentation thumbnail
Role of cardioversion in the management of non-valvular atrial fibrillation: insights from the GARFIELD-AF registry
Doctor V. Schirripa (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Cryoballoon versus radiofrequency ablation for atrial fibrillation - a study of outcome and safety based on the ESC-EHRA AF ablation long-term registry and the Swedish catheter ablation registry
Professor M. Blomstrom-Lundqvist (Orebro, SE)
Abstract Slides Video
Presentation thumbnail
Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation: the protective role of antiarrhythmic drug therapy
Doctor J. Mesquita (Lisbon, PT)
Abstract Slides Video
Presentation thumbnail
Long-term outcome of pulmonary vein isolation versus amiodarone therapy in patients with coexistent persistent atrial fibrillation and congestive heart failure
Doctor S. Mohanty (Austin, US)
Abstract Slides Video
Presentation thumbnail
Significance of left atrial appendage isolation in patients with long-standing persistent atrial fibrillation undergoing catheter ablation
Doctor S. Mohanty (Austin, US)
Abstract Slides Video

Access the full session

Session thumbnail
Treatment of atrial fibrillation

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources